MAXYGENE Trademark

living plants, namely transgenic plants

directed evolution services, namely the recombination of genes customized to the specification of others to produce novel gene sequences for use in science, research, chemistry, agriculture, medicine, and industry

pharmaceutical preparations for the prevention and treatment of cardiovascular, dental and periodontal, dermatologic, endocrine and metabolic, gastrointestinal, genetic, hematologic, hepatic, immunologic, lymphatic, osteologic, neurologic, ophthalmic, psychiatric, respiratory tract, and renal and urinary tract diseases and disorders; pharmaceutical preparations, namely, analgesics, antibiotics, anti-cancer preparations, anti-infectives, anti-parsitics, antivirals; insulin; hormones; medical diagnostic preparations and reagents; herbicides, pesticides, biopesticides, miticides, and weed killers, all for agricultural and domestic use; vaccines; adjuvents for use with vaccines

biochemicals, namely, polynucleic acids and polypeptides for scientific, research and commercial use; biochemicals for in vitro and in vivo scientific, research and commercial use; plant growth regulators; polypeptides, genes and polynucleic acids for agricultural use; and genes and enzymes used to produce chemicals for research and commercial applications pertaining to chemistry, biochemistry, biology, agriculture, pharmaceuticals, diagnostics, medicine, bioremediation, decontamination, detoxification, and cleaning

chemical research services; scientific research services; research and testing services in the fields of bacteriology and virology; research and product development services for others in the fields of genetics and gene therapy, transgenic plants, chemistry, pharmaceuticals, medical diagnostics, pesticides, biopesticides, cytotoxic agents, bacteriology, virology, biocatalysis, metabolic pathways and biochemical pathways